D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAC
3976
CALL
Lithium Americas
LAC
$986M
| $134K | ﹤0.01% |
50,000
| – | – |
|
3977
Orion Group Holdings
ORN
$514M
| $133K | ﹤0.01% |
14,715
-50,154
| -77% | -$376K |
|
|
GTENW
3978
Gores Holdings X Warrants
GTENW
$7.62M
| $133K | ﹤0.01% |
+225,000
| New | +$134K |
|
|
FBLA
3979
FB Bancorp
FBLA
$251M
| $132K | ﹤0.01% |
+11,758
| New | +$130K |
|
3980
Clover Health Investments
CLOV
$2.28B
| $131K | ﹤0.01% |
+46,959
| New | +$154K |
|
3981
Cosan
CSAN
$2.96B
| $131K | ﹤0.01% |
25,879
-258,923
| -91% | -$1.4M |
|
3982
CALL
TripAdvisor
TRIP
$1.59B
| $131K | ﹤0.01% |
10,000
| – | – |
|
3983
LXP Industrial Trust
LXP
$3.53B
| $130K | ﹤0.01% |
3,150
-7,355
| -70% | -$303K |
|
3984
PUT
Wolfspeed
WOLF
$1.2B
| $130K | ﹤0.01% |
325,000
-180,000
| -36% | -$410K |
|
3985
Gran Tierra Energy
GTE
$260M
| $129K | ﹤0.01% |
27,089
-8,358
| -24% | -$39.6K |
|
|
SUPV
3986
CALL
Grupo Supervielle
SUPV
$833M
| $128K | ﹤0.01% |
12,100
| – | – |
|
3987
C4 Therapeutics
CCCC
$376M
| $128K | ﹤0.01% |
89,475
+10,200
| +13% | +$14.8K |
|
3988
Arbutus Biopharma
ABUS
$865M
| $126K | ﹤0.01% |
+40,700
| New | +$135K |
|
3989
FreightCar America
RAIL
$275M
| $124K | ﹤0.01% |
+14,400
| New | +$100K |
|
|
MLACR
3990
DELISTED
Mountain Lake Acquisition Corp Right
MLACR
| $123K | ﹤0.01% |
725,000
| – | – |
|
3991
Aspen Aerogels
ASPN
$387M
| $123K | ﹤0.01% |
20,722
-4,067
| -16% | -$23.4K |
|
3992
MacroGenics
MGNX
$235M
| $122K | ﹤0.01% |
100,511
+71,811
| +250% | +$104K |
|
3993
Vodafone
VOD
$34.9B
| $121K | ﹤0.01% |
11,373
-1,084,299
| -99% | -$10.5M |
|
|
BTX
3994
BlackRock Technology and Private Equity Term Trust
BTX
$957M
| $120K | ﹤0.01% |
16,406
-18,733
| -53% | -$124K |
|
|
VERV
3995
DELISTED
Verve Therapeutics
VERV
| $119K | ﹤0.01% |
10,586
-46,518
| -81% | -$265K |
|
3996
Mizuho Financial
MFG
$129B
| $114K | ﹤0.01% |
+20,454
| New | +$106K |
|
3997
Mitek Systems
MITK
$762M
| $113K | ﹤0.01% |
+11,460
| New | +$103K |
|
3998
Destination XL Group
DXLG
$34.7M
| $113K | ﹤0.01% |
101,674
-6,340
| -6% | -$6.94K |
|
3999
PetMed Express
PETS
$42.5M
| $112K | ﹤0.01% |
33,678
-3,422
| -9% | -$12.2K |
|
|
ATIIW
4000
Archimedes Tech SPAC Partners II Co Warrant
ATIIW
$21.3M
| $111K | ﹤0.01% |
+287,500
| New | +$88.8K |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.